Search
for

    Sort by

    Research 121–150 of 527

    1. Hair Changes due to Drugs Elsevier eBooks · 2018
    2. Détection précoce de la cardiotoxicité due à la doxorubicine chez le miniporc par imagerie par résonance magnétique PolyPublie (École Polytechnique de Montréal) · 2016
    3. Skin Disorders Pathy's Principles and Practice of Geriatric Medicine · 2012
    4. Oral zinc sulphate in treatment of patients with thallium poisoning: A clinical therapeutic trial Journal of clinical and experimental investigations · 2011
    5. Was the epidemic skin disease of 1891 due to acute arsenic poisoning? British Journal of Dermatology · 2011
    6. Original article / Article original External post mortem artefact: a key issue in hair result interpretation 2009
    7. Cutaneous manifestations of systemic infection in children Current problems in dermatology · 1993
    8. MOST IMPORTANT SKIN DISEASES OF CHILDRENTheir Diagnosis and Treatment Archives of pediatrics & adolescent medicine · 1955
    9. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertility and Sterility · 2004 · 4809 citations
    10. Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline The Journal of Clinical Endocrinology and Metabolism · 2006 · 1744 citations
    11. The Nuts and Bolts of Low-level Laser (Light) Therapy Annals of Biomedical Engineering · 2011 · 1057 citations
    12. Polycystic ovary syndrome The Lancet · 2007 · 989 citations
    13. Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study<sup>1</sup> The Journal of Clinical Endocrinology and Metabolism · 1998 · 633 citations
    14. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocrine Reviews · 2008 · 343 citations
    15. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome Human Reproduction Update · 2009 · 286 citations
    16. Serotoninergic and melatoninergic systems are fully expressed in human skin ˜The œFASEB journal · 2002 · 249 citations
    17. Development of polycystic ovary syndrome: involvement of genetic and environmental factors Andrology · 2005 · 232 citations
    18. Volatile signalling by sesquiterpenes from ectomycorrhizal fungi reprogrammes root architecture Nature Communications · 2015 · 193 citations
    19. Roles of <i>jumonji</i> and <i>jumonji</i> family genes in chromatin regulation and development Developmental Dynamics · 2006 · 178 citations
    20. Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice Journal of The American Academy of Dermatology · 2004 · 172 citations
    21. Adult polycystic ovary syndrome begins in childhood Best Practice & Research Clinical Endocrinology & Metabolism · 2002 · 124 citations
    22. Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia Frontiers in Bioengineering and Biotechnology · 2020 · 119 citations
    23. A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection The Milbank Quarterly · 2006 · 108 citations
    24. MENSTRUAL DISORDERS IN ADOLESCENTS Pediatric Clinics of North America · 1999 · 75 citations
    25. Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment Endocrine journal · 2006 · 74 citations
    26. Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries The Journal of Clinical Endocrinology and Metabolism · 2008 · 73 citations
    27. Next generation human skin constructs as advanced tools for drug development Experimental Biology and Medicine · 2017 · 69 citations
    28. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance Clinical Medicine · 2015 · 62 citations
    29. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study BMJ · 2021 · 59 citations
    30. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer Breast Cancer Research and Treatment · 2016 · 59 citations